FDA Approves Fluzone High-Dose Quadrivalent (Influenza Vaccine) for Adults 65 Years of Age and Older

FDA News, New FDA Approvals
November 4, 2019
A+ A-
Email Print

Article Link: FDA Approves Fluzone High-Dose Quadrivalent (Influenza Vaccine) for Adults 65 Years of Age and Older

PARIS, Nov. 4, 2019 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone High-Dose Quadrivalent (Influenza Vaccine) for use in adults 65 years of age and older.
Fluzone…

Source: FDA New Drug Approvals

Posted by

Newer Post
Older Post